Search Results

You are looking at 21 - 30 of 40 items for :

  • "Pancreas cancer" x
  • Refine by Access: All x
Clear All
Full access

Sheshadri Madhusudhana, Michelle Gates, Daulath Singh, Punita Grover, Mahathi Indaram, and An-Lin Cheng

associated with worse survival in stage I colorectal cancers, stage I–III breast and renal cancers, and stage I–II non–small cell lung and pancreas cancers. 3 The same effect has been found in early-stage liver cancer. 4 Delays in administration of

Full access

Andrew H. Ko and Christopher H. Crane

concurrent gemcitabine with radiotherapy in this disease is also a reasonable option, because it is a proven systemic agent in pancreas cancer and has radiosensitizing properties, although it is potentially more toxic to the gastrointestinal mucosa. In the

Full access

Zhi Ven Fong and Cristina R. Ferrone

, Aizenberg R , Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States . Cancer Res 2014 ; 74 : 2913 – 2921 . https://doi.org/10.1158/0008-5472.CAN-14-0155PubMed 10

Full access

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud Al-Hawary, Horacio Asbun, Andrew Bain, Stephen W. Behrman, Al B. Benson III, Ellen Binder, Dana B. Cardin, Charles Cha, E. Gabriela Chiorean, Vincent Chung, Brian Czito, Mary Dillhoff, Efrat Dotan, Cristina R. Ferrone, Jeffrey Hardacre, William G. Hawkins, Joseph Herman, Andrew H. Ko, Srinadh Komanduri, Albert Koong, Noelle LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Eileen M. O'Reilly, Jorge Obando, Sushanth Reddy, Courtney Scaife, Sarah Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer Burns, and Susan Darlow

III Moore MJ Andersen J . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial . J Clin Oncol 1997 ; 15 : 2403 – 2413 . 43. Oettle H Post S

Full access

Michael Cecchini, Jeffrey Sklar, and Jill Lacy

. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer . N Engl J Med 2011 ; 364 : 1817 – 1825 . 4. Chantrill LA Nagrial AM Watson C . Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer

Full access

Jordan M. Cloyd, Chengli Shen, Heena Santry, John Bridges, Mary Dillhoff, Aslam Ejaz, Timothy M. Pawlik, and Allan Tsung

Research and Treatment of Cancer trial 10902 . J Clin Oncol 2001 ; 19 : 4224 – 4237 . 10.1200/JCO.2001.19.22.4224 31. Abraham A , Al-Refaie WB , Parsons HM , . Disparities in pancreas cancer care . Ann Surg Oncol 2013 ; 20 : 2078 – 2087 . 10

Full access

Alexander P. Cole, Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz, Brandon A. Mahal, Paul L. Nguyen, Toni K. Choueiri, Adam S. Kibel, Adil H. Haider, and Quoc-Dien Trinh

. Abraham A , Al-Refaie WB , Parsons HM , . Disparities in pancreas cancer care . Ann Surg Oncol 2013 ; 20 : 2078 – 2087 . 10.1245/s10434-012-2843-z 23579872 22. Bristow RE , Powell MA , Al-Hammadi N , . Disparities in ovarian cancer

Full access

Margaret A. Tempero, J. Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B. Benson III, Jordan D. Berlin, John L. Cameron, Ephraim S. Casper, Steven J. Cohen, Michelle Duff, Joshua D.I. Ellenhorn, William G. Hawkins, John P. Hoffman, Boris W. Kuvshinoff II, Mokenge P. Malafa, Peter Muscarella II, Eric K. Nakakura, Aaron R. Sasson, Sarah P. Thayer, Douglas S. Tyler, Robert S. Warren, Samuel Whiting, Christopher Willett, and Robert A. Wolff

lymphatic and connective tissue clearance for the carcinoma of the pancreas head . Ann Surg 1988 ; 208 : 215 – 220 . 135. Manabe T Ohshio G Baba N . Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas . Cancer 1989

Full access

Julie Hallet, Laura Davis, Alyson Mahar, Michail Mavros, Kaitlyn Beyfuss, Ying Liu, Calvin H.L. Law, Craig Earle, and Natalie Coburn

-term survival for cancer surgery . J Clin Oncol 2008 ; 26 : 4626 – 4633 . 10.1200/JCO.2007.15.6356 18574159 4. Simunovic M , Urbach D , Major D , . Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas

Full access

Lingling Du and Andrea Wang-Gillam

MJ Andersen J . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial . J Clin Oncol 1997 ; 15 : 2403 – 2413 . 15. Evans DB Varadhachary GR